Company information:
Re-Vana Therapeutics Ltd (No: NI638333)
Address: 63 UNIVERSITY ROAD, BELFAST, BT7 1NF, NORTHERN IRELAND
Status: Active
Incorporated: 05-Sep-2016
Accounts Next Due: 31-May-2024
Next Confirmation Statement Due: 28-Mar-2025
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: ROBERT LOGAN AVERY ( DOB: May-1960 From: Nov-2022 )
Current Director: GARRETT HAMONTREE ( DOB: Jul-1989 From: May-2020 )
Current Director: JAMES MURRAY ( DOB: Apr-1981 From: Mar-2020 )
Current Director: MICHAEL JOSEPH O'ROURKE ( From: May-2017 )
Current Director: ANNA SUMERAY ( DOB: Jul-1965 From: Nov-2021 )
Resigned Director: ROBERT IAN GRUNDY ( From: May-2016 To: May-2017 )
Resigned Director: DAVID SIMON JONES ( DOB: May-1963 From: May-2016 To: Dec-2017 )
Resigned Director: BRIAN AIDAN MCCAUL ( DOB: Oct-1966 From: May-2016 To: Nov-2022 )
Resigned Director: KIERAN FRANCIS ROONEY ( DOB: Sep-1960 From: Sep-2017 To: Nov-2022 )
Resigned Director: JAMES ANTHONY SHARKEY ( DOB: Dec-1961 From: Nov-2017 To: Nov-2021 )
Resigned Director: RAGHU RAJ SINGH THAKUR ( DOB: Sep-1979 From: Jul-2016 To: Nov-2022 )
Resigned Director: HENRY RICHARD ERNEST WILSON ( DOB: Oct-1966 From: Nov-2017 To: May-2020 )
Persons of Significant Control:
Qubis Limited, 63 University Road 63 University Road, 63 University Road, Belfast, BT7 1NF, Northern Ireland: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2016-05-16, Ceased: 2017-12-13)
Dr. Raghu Raj Singh Thakur, 63 University Road 63 University Road, 63 University Road, Belfast, BT7 1NF, Northern Ireland: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2016-05-16, Ceased: 2017-12-13)
Company Accounts Summary (£)
| Item | 17 | 18 | 19 | 20 | 21 | 22 | 23 | Chart |
|---|---|---|---|---|---|---|---|---|
| Current assets | 34,708 | 784,771 | 525,044 | 2,649,731 | 1,753,879 | 961,358 | 5,278,895 | 34708.0,784771.0,525044.0,2649731.0,1753879.0,961358.0,5278895.0 |
| Net current assets (liabilities) | 45,114 | 768,268 | 488,443 | 2,562,298 | 1,613,155 | 921,243 | 5,142,819 | 45114.0,768268.0,488443.0,2562298.0,1613155.0,921243.0,5142819.0 |
| Total assets less current liabilities | 45,114 | 768,268 | 488,443 | 2,562,298 | 1,615,143 | 922,237 | 5,212,586 | 45114.0,768268.0,488443.0,2562298.0,1615143.0,922237.0,5212586.0 |
| Net assets (liabilities) | 45,114 | 768,268 | 488,443 | 2,562,298 | 1,614,418 | 921,337 | 5,210,636 | 45114.0,768268.0,488443.0,2562298.0,1614418.0,921337.0,5210636.0 |
| Equity / share capital and reserves | 45,114 | 768,268 | 488,443 | 2,562,298 | 1,614,418 | 45114.0,768268.0,488443.0,2562298.0,1614418.0,0.0,0.0 |